The assessment of patients' health-related quality of life during tuberculosis treatment in Wuhan, China

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 9, 2004, Pages 1100-1106

  Chamla, D ^a  

^a République Démocratique du Congo   (China)

Author keywords

Health related quality of life (HQoL); SF 36; Tuberculosis (TB)

Indexed keywords

HEMOGLOBIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CELL COUNT; CHINA; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMOTION; GENDER; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MENTAL HEALTH; NONHUMAN; PATIENT MONITORING; POPULATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; REGRESSION ANALYSIS; SCORING SYSTEM; SOCIAL STATUS; TUBERCULOSIS; VALIDATION PROCESS;

ADULT; ANTITUBERCULAR AGENTS; CHINA; FEMALE; HEALTH STATUS; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 4444299552     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Wang Y, Lii J, Lu F. Measuring and assessing the quality of life of patients with pulmonary tuberculosis. [Article in Chinese] Zhonghua Jie He He Hu Xi Za Zhi 1998; 21: 720-723.
2. Tamm I. Decrease in tuberculosis mortality-a credit to medicine or sequela of an improved standard of living. Offentl Gesundheitswes 1990; 52: 58-64.
3. Ravligione M C, Snider D, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of worldwide epidemic. JAMA 1995; 273: 220-226.
4. World Health Organization. Anti-TB resistance in the world; Report no. 2: Prevalence and Trend. The WHO/IUATLD global project on anti-TB drug resistance surveillance. WHO/ CDS/TB/2000.278. Geneva, Switzerland: WHO, 2000.
5. Wang L X, Liu S G, Wang X J. Study on geographic distribution of smear-positive pulmonary tuberculosis with trend-surface analysis. [Article in Chinese] Zhonghua Liu Xing Bing Xue Za Zhi 1995; 16: 274-276.
6. Peng J. Symptomatic survey on pulmonary tuberculosis in Shanghai rural areas. [Article in Chinese] Zhonghua Jie He He Huxi Zazhi 1993; 16: 83-84, 123.
7. Zhung Y, Fong X, Chen Y, et al. A surveillance study on epidemiology of tuberculosis in urban area of Wuhan. [Article in Chinese] Zhong Hua Jie He He Huxi Zazhi 1987; 10: 99-101.
8. Wuhan TB Control Centre. Annual report on Tuberculosis in Wuhan city 2001. Wuhan, China: Wuhan TB Control Centre, 2002.
9. The WHOQOL GROUP. The WHOQOL: Position paper from the WHO. Soc Sci Med 1995; 41: 1403-1409.
10. Garratt A M, Ruta D A, Abdalla M I, Buckingham J K, Russell I T. The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? BMJ 1993; 306: 1440-1444.
11. Guyatt G, Berman L, Townsend M. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
12. Lyons R A, Perry H M, Littlepage B N. Evidence for the validity of the Short-form 36 Questionnaire (SF-36) in an elderly population. Age & Ageing 1994; 23: 182-184.
13. Ware J J, Sherbourne C D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care 1992; 30: 473-483.
14. Brazier J E, Harper R, Jones N M, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305: 160-164.
15. Ware J E, Keller S D. Interpreting general health measures. In: Spilker B, ed. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. Philadelphia, PA: Lippincott-Raven, 1996.
16. Ware J E, Snow K K, Kosisnki M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, 1993.
17. Jungbauer J S, Fuller B. Feasibility of a multi-state outcomes program for cardiopulmonary rehabilitation. J Cardiopulmonary Rehabil 1999; 19: 352-359.
18. Jette D U, Downing J. Health status of individuals entering a cardiac rehabilitation program as measured by the Medical Outcomes Study 36-Item Short-Form Survey (SF-36). Phys Ther 1994; 74: 521-527.
19. World Health Organization. TB/HIV a clinical manual. WHO/ TB/96.200. Geneva, Switzerland: WHO, 1996.
20. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2002. WHO/CDS/TB/2002.295. Geneva, Switzerland: WHO, 2002.
21. Zafran E, Heldal S. Why do our patients die of active tuberculosis in the era of effective therapy. Tubercle Lung Dis 1994; 75: 329-333.
22. Ware J E, Gandek B. Methods for testing data quality, scaling assumptions and reliability; The IQOLA Project Approach. J Clin Epidem 1998; 51: 945-952.
23. Xinhua S R, Amik B, Zhou L, Gandek B. Translation and Psychometric evaluation of Chinese version of the SF-36 health survey in the US. J Clin Epidem 1998; 51: 1129-1135.
24. Harmann H H. Modern factor analysis. 3rd ed. Revised. Chicago, IL: University of Chicago Press, 1976.
25. Ware J E, Kosinski M. SF-36 Physical & Mental Health Summary Scales: A Manual for Users of Version 1. 2nd ed. Lincoln, Rl: Quality Metric, 2001.
26. Ware J E. Standards for validating health measures: definitions and contents. J Chronic Dis 1987; 40: 473-480.
27. Ware J E Jr, Gandek B, Kosinski M, et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1167-1170.
28. Thumboo J, Fong K Y, Chan S P. The equivalence of English and Chinese SF-36 versions in bilingual Singapore Chinese. Qual Life Res 2002; 11: 495-503.
29. Ware J E Jr, Kosinski M, Gandek B. The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1159-1165.
30. Gandek B, Ware J E Jr, Aaronson N K, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1149-1158.
31. Aydin I O, Ulusahin A. Depression, anxiety cormobidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001; 23: 77-83.
32. Shanghai Pulmonary Tuberculosis Epidemiological Research Group. A three year retrospective cohort study on pulmonary tuberculosis in Shanghai. [Article in Chinese] Zhonghua Jie He He Huxi Zazhi 1995; 18: 309-312, 319-320.
33. Liu X R. A relapse and its potential causes in pulmonary tuberculosis. [Article in Chinese] Zhonghua Jie He He Huxi Zazhi 1993; 16: 66-72, 122.
34. Liu J, Xiong C, Wang X, et al. Analysis on effects of TB control project loaned by World Bank in Hubei. [Article in Chinese] Zhongguo Fang Lao Zazhi 2001; 23: 91-94.
35. Hong Kong Chest Service/British Medical Research Council. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Am Rev Respir Dis 1987; 136: 1339-1342.
36. Dye C. Tuberculosis 2000-2010: control but not elimination. Int J Tuberc Lung Dis 2000; 4 (Suppl 2): s146-s152.
37. Karyadi E, Schultink W, Nelwan R H, et al. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr 2000; 130: 2953-2958.
38. Nunez-Rocha G M, Salinas-Martinez A M, Villarreal-Rios E, Garza-Elizondo M E, Gonzalez-Rodriguez F. Nutritional risk in patients with pulmonary tuberculosis: the patient's or the health services' problem? [Article in Spanish] Salud Publica Mex 2000; 42: 126-132.
39. Macallan D C, McNurlan M A, Kurpad A V, et al. Whole body protein metabolism in human pulmonary tuberculosis and undernutrition: evidence for anabolic block in tuberculosis. Clin Sci (Lond) 1998; 94: 321-331.
40. Chandra R K. Nutrition and the immune system: an introduction. Am J Clin Nutr 1997; 66: 460S-463S.
41. Madebo T, Nysaeter G, Lindtjorn B. HIV infection and malnutrition change the clinical and radiological features of pulmonary tuberculosis. Scand J Infect Dis 1997; 29: 355-359.
42. Niyongabo T, Henzel D, Ndayishimyie J M, et al. Nutritional status of adult inpatients in Bujumbura, Burundi (impact of HIV infection). Eur J Clin Nutr 1999; 53: 579-582.
43. Macallan D C. Malnutrition in tuberculosis. Diagn Microbiol Infect Dis 1999; 34: 153-157.
44. Kennedy N, Ramsay A, Uiso L, Gutmann J, Ngowi F I, Gillespie S H. Nutritional status and weight gain in patients with pulmonary tuberculosis in Tanzania. Trans R Soc Trop Med Hyg 1996; 90: 162-166.
45. Onwubalili J K. Malnutrition among tuberculosis patients in Harrow, England. Eur J Clin Nutr 1988; 42: 363-366.